Literature DB >> 23509482

A description of a multistaged professional development course for practising pharmacists in anticoagulation management.

Tammy J Bungard, Theresa J Schindel, Cynthia Brocklebank.   

Abstract

Year:  2012        PMID: 23509482      PMCID: PMC3567540          DOI: 10.3821/1913-701X-145.1.14

Source DB:  PubMed          Journal:  Can Pharm J (Ott)        ISSN: 1715-1635


× No keyword cloud information.
  5 in total

1.  Evaluation of a multi staged professional development course for practising pharmacists in anticoagulation management.

Authors:  Tammy J Bungard; Theresa J Schindel; Sipi Garg; Cynthia Brocklebank
Journal:  Int J Pharm Pract       Date:  2011-10-13

2.  'Effectiveness of Continuing Professional Development' project: a summary of findings.

Authors:  Jill Schostak; Mike Davis; Jacky Hanson; John Schostak; Tony Brown; Peter Driscoll; Ian Starke; Nick Jenkins
Journal:  Med Teach       Date:  2010       Impact factor: 3.650

Review 3.  Consensus guidelines for coordinated outpatient oral anticoagulation therapy management. Anticoagulation Guidelines Task Force.

Authors:  J E Ansell; M L Buttaro; O V Thomas; C H Knowlton
Journal:  Ann Pharmacother       Date:  1997-05       Impact factor: 3.154

4.  Prescribing by pharmacists in Alberta.

Authors:  Nese Yuksel; Greg Eberhart; Tammy J Bungard
Journal:  Am J Health Syst Pharm       Date:  2008-11-15       Impact factor: 2.637

5.  Delivery of optimized anticoagulant therapy: consensus statement from the Anticoagulation Forum.

Authors:  David A Garcia; Daniel M Witt; Elaine Hylek; Ann K Wittkowsky; Edith A Nutescu; Alan Jacobson; Stephan Moll; Geno J Merli; Mark Crowther; Laura Earl; Richard C Becker; Lynn Oertel; Amir Jaffer; Jack E Ansell
Journal:  Ann Pharmacother       Date:  2008-06-17       Impact factor: 3.154

  5 in total
  1 in total

1.  University-based continuing education for pharmacists.

Authors:  Theresa J Schindel; James P Kehrer; Nesé Yuksel; Christine A Hughes
Journal:  Am J Pharm Educ       Date:  2012-03-12       Impact factor: 2.047

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.